Clin Endosc.  2012 Nov;45(4):451-452.

Lesion Location in Clinical Significance of Incidental Colorectal FDG Uptake

• Lee JC
• Hartnett G
• Ravi Kumar AS

Abstract

No abstract available.

Reference

1. Roh SH, Jung SA, Kim SE, et al. The clinical meaning of benign colon uptake in 18F-FDG PET: comparison with colonoscopic findings. Clin Endosc. 2012; 45:145–150. PMID: 22866255.

2. Lee JC, Hartnett GF, Hughes BG, Ravi Kumar AS. The segmental distribution and clinical significance of colorectal fluorodeoxyglucose uptake incidentally detected on PET-CT. Nucl Med Commun. 2009; 30:333–337. PMID: 19262416.

3. Jang BI. Benign colonic 18F-FDG uptake on whole-body FDG-PET scan. Clin Endosc. 2012; 45:109–110. PMID: 22866246.

4. Israel O, Yefremov N, Bar-Shalom R, et al. PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. J Nucl Med. 2005; 46:758–762. PMID: 15872347.

5. Kamel EM, Thumshirn M, Truninger K, et al. Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results. J Nucl Med. 2004; 45:1804–1810. PMID: 15534047.

6. Wang K, Chen YC, Palmer MR, et al. Focal physiologic fluorodeoxyglucose activity in the gastrointestinal tract is located within the colonic lumen. Nucl Med Commun. 2012; 33:641–647. PMID: 22240934.